Corticosteroid Therapy in COVID-19 Disease

被引：0

作者：

Akbudak, Ismail Hakki ^{[1
]}

机构：

[1] Pamukkale Univ, Dept Internal Med, Div Intens Care Med, Fac Med, Denizli, Turkey

来源：

JOURNAL OF CRITICAL & INTENSIVE CARE | 2020年 / 11卷

关键词：

Septic Shock; Coronavirus Infections; Respiratory Failure; Corticosteroids;

D O I：

10.37678/dcybd.2020.2349

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Corticosteroid therapy has been used for many years and is still controversial in use. In the Coronovirus disease 2019 (COVID-19) outbreak, it is very important to find reliable treatment information for clinicians and patients. Low dose corticosteroids are also used in patients with septic shock, relative adrenal insufficiency and acute respiratory distress syndrome (ARDS). There is not enough evidence for its use in COVID-19. However, low dose use is recommended in the case of ARDS and septic shock in COVID-19 patients. Caution should be exercised until further evidence emerges surrounding the use of corticosteroids in COVID-19 patients.

引用

页码：30 / 31

页数：2

共 50 条

[1] Coronavirus disease (COVID-19)-associated mucormycosis (CAM): The unholy triad of COVID-19, diabetes mellitus, and corticosteroid therapy
Juyal, Deepak
Pal, Shekhar
Negi, Nidhi
Singh, Minakshi
Kumar, Manish
Singhal, Shweta
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (11) : 2538 - 2541
[2] Pros and cons of corticosteroid therapy for COVID-19 patients
Mattos-Silva, Paula
Felix, Nathane Santanna
Silva, Pedro Leme
Robba, Chiara
Battaglini, Denise
Pelosi, Paolo
Macedo Rocco, Patricia Rieken
Cruz, Fernanda Ferreira
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2020, 280
[3] Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations
Sichitiu, Joanna
Fakhouri, Fadi
Desseauve, David
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (07) : 952 - 952
[4] Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease
Shroff, Daraius
Narula, Ritesh
Atri, Neelam
Chakravarti, Arindam
Gandhi, Arpan
Sapra, Neelam
Bhatia, Gagan
Pawar, Shraddha R.
Narain, Shishir
INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (07) : 1909 - 1914
[5] Adjuvant corticosteroid therapy for critically ill patients with COVID-19
Lu, Xiaofan
Chen, Taige
Wang, Yang
Wang, Jun
Yan, Fangrong
CRITICAL CARE, 2020, 24 (01)
[6] Potential benefits of precise corticosteroid therapy for critical COVID-19
Chen, Qingquan
Yang, Qiongxiu
Fang, Yingying
Chen, Gongping
Lv, Xiaoting
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2022, 297
[7] Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection
Mehrabi, Zeinab
Salimi, Maryam
Niknam, Kianoush
Mohammadi, Farzaneh
Mamaghani, Hesan Jelodari
Sasani, Mohammad Reza
Ashraf, Mohammad Javad
Salimi, Amirhossein
Zahedroozegar, Mohammad Hassan
Erfani, Zohreh
CASE REPORTS IN OPHTHALMOLOGICAL MEDICINE, 2021, 2021
[8] Adjuvant corticosteroid therapy for critically ill patients with COVID-19
Xiaofan Lu
Taige Chen
Yang Wang
Jun Wang
Fangrong Yan
Critical Care, 24
[9] Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
Zha, Lei
Li, Shirong
Pan, Lingling
Tefsen, Boris
Li, Yeshan
French, Neil
Chen, Liyun
Yang, Gang
Villanueva, Elmer V.
MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (09) : 416 - 420
[10] Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients
Mandadi, Subhadra
Pulluru, Harish
Annie, Frank
PLOS ONE, 2022, 17 (02):

← 1 2 3 4 5 →